RecruitingNot ApplicableNCT07615686

tSCS in Children With Spina Bifida

Transcutaneous Spinal Cord Stimulation to Improve Strength and Gait in Children With Spina Bifida

Sponsor

Bailey Petersen

Enrollment

20 participants

Start Date

Aug 30, 2026

Study Type

INTERVENTIONAL

Conditions

Myelomeningocele Spina Bifida

Summary

A single-center, open-label, investigational pilot trial to explore potential effects of transcutaneous spinal cord stimulation on leg muscle strength and walking in children with myelomeningocele.

Eligibility

Min Age: 4 YearsMax Age: 17 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Transcutaneous stimulator for people with myelomeningocele and spina bifida. The study is currently recruiting participants at 1 location. People eligible for this study include aged 4 Years to 17 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.